D3.3 2nd Dissemination and Communication Activities

Oct 18, 2023 | Deliverables

The deliverable (D3.3) describes all Communication and Dissemination activities that have taken
place during the period 1/4/2022-30/9/2023. Scope of the activities is to maximize the impact
and the awareness of the project. All tasks have involved the whole consortium to ensure their
buy-in.
The 2 nd Dissemination and Communication Activities Report builds mostly upon all the activities
that have taken place since the beginning of the project. The deliverable is updated every one
and a half year up to now, along with the Reporting period of the project.
The report presents a detailed overview of the dissemination activities during M19-36 for the
ProCAncer-I project. It includes the objectives of the activities, target groups, promotional tools
and material, and visual identity among other strategies. All tools are being used to raise
worldwide awareness and principally act as the brand guidelines of the project. Also, the
deliverable reports all the actions that have been concluded up to M36 for the dissemination of
the project

Highlights

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

The role of artificial intelligence (AI) in healthcare is expanding rapidly, but trust remains a crucial barrier to its widespread adoption. The following AI-generated audio file, titled, serves as an example of how AI-driven technologies can contribute to medical research and education.

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

ProCAncer-I organised the 4th Dissemination Event of the project at the ECR 2025 held in Vienna, Austria, February 25-26, 2025. During the congress, ProCAncer-I organised a Dedicated Session on the project on the 26th of February 2025, at 15.00-16.00, with the title...

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

Twitter feed is not available at the moment.

Stay in touch!